Mini Program: A-share pre-market news quick delivery.
Important news
1. The National Internet Information Office vigorously combats online financial chaos: a heavy crackdown on illegal stock recommendations and inducement behaviors.
Since the beginning of this year, the National Internet Information Office has thoroughly implemented the work deployment of the Central Committee of the Communist Party of China and the State Council, maintaining a high-pressure crackdown on online financial information chaos. Together with relevant departments, it has dealt with a batch of accounts engaged in illegal stock recommendation, illegal financial intermediary activities on platforms such as Douyin, Kuaishou, Weibo, and WeChat, clearing out financial sector traffic and inducement-related illegal information, and increasing penalties against websites and accounts engaged in financial-related businesses without qualifications. For websites and platforms engaged in loan assistance, they are required to standardize the display of marketing information and the settings of marketing functions, and enhance the disclosure of information risks. In the next step, the National Internet Information Department will continue to strengthen the crackdown on online financial information chaos, standardize the dissemination order of online financial information, and strive to safeguard the property safety of the people. (Internet Information China)
2. Personal pension expansion upgrade: Pilot coverage nationwide and add more than 20 broad-based index funds.
The personal pension pilot will soon be fully opened, expanding from the original 36 pilot cities to the entire country. At the same time, personal pension fund products are also welcoming expansion, with some mature broad-based ETF linked funds and broad-based index off-market products adding Y shares. It is reported that the products eligible for personal pensions may include nearly 20 broad-based index off-market products tracking the CSI 300 Index, CSI 500 Index, CSI 800 Index, GEM Index, STAR 50 Index, etc. (21 Finance)
3. Financial Times: The pressure from a strong dollar is expected to weaken, and the RMB is likely to stabilize and rebound by the end of the year.
A commentary article published by the media under the central bank (Financial Times) stated that recently, after the U.S. election, the market has been speculating on Trump’s transactions, significantly boosting the U.S. dollar index, which peaked above 108, putting pressure on non-U.S. currencies. The RMB exchange rate has been fluctuating in both directions, with increased elasticity, and the market expectations are relatively stable, with enterprises' foreign exchange purchase and sale behavior rational and orderly, and the overall operation of the foreign exchange market is stable. Many industry experts believe that the possibility of the U.S. dollar declining is increasing, and China’s economic development is steadily improving. From both internal and external conditions, the RMB exchange rate maintains basic stability at a reasonable and balanced level, with a high probability of stabilizing and rising as the end of the year approaches and enterprises increase their foreign exchange settlement.
4. The tenth batch of national procurement has started: 62 varieties are open for bidding, with scale hitting a new high, and many heavy varieties worth over 2 billion participate in bidding.
The tenth batch of national organized drug centralized procurement officially accepted enterprise application materials at 8 a.m. today at 398 Zhan Yuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involves 62 varieties and 263 specifications, with both the number of enterprises and varieties involved reaching a historical high. Among them, there are 33 enterprises competing for 9 qualifications for the oral release form of sitagliptin, as well as multiple varieties in the billion-level public hospital market, such as liposomal doxorubicin injection, cefoperazone injection, piperacillin injection, compound α-keto acid oral sustained-release form, norepinephrine injection, and aspirin oral sustained-release form, all of which exceeded 2 billion yuan in sales scale in last year's sample hospitals. Heng Rui Pharmaceutical, Kelun Pharmaceutical, Shiyao Group, and Zhengda Tianqing participated with multiple varieties. According to the previously released tenth batch of national procurement documents, there have been many changes in the rules for the tenth batch of national procurement, such as the cancellation of the 50% price reduction protection mechanism, the addition of a 1.8 times circuit breaker revival mechanism, and the impact of the number of B certificate enterprises on the final number of enterprises selected.
5. The U.S. Department of Commerce placed two Chinese high-tech companies on the 'Entity List' on the grounds of 'human rights violations,' and the Ministry of Foreign Affairs responded: It is a blatant suppression of Chinese high-tech companies under the guise of human rights.
On December 11, the spokesperson of the Ministry of Foreign Affairs, Mao Ning, hosted a regular press conference. On December 10, the U.S. Department of Commerce placed two Chinese high-tech companies on the 'Entity List' on the grounds of 'human rights violations.' What is China's comment on this? Mao Ning: The so-called sanctions you mentioned are a blatant suppression of Chinese high-tech companies under the guise of human rights, further exposing the hypocrisy of the U.S. side in claiming to protect human rights while actually depriving the Chinese people of their right to development. Such tricks are bound to fail. If the U.S. truly cares about human rights, it should first address its own human rights 'deficits' rather than politicizing and weaponizing human rights issues, interfering in the internal affairs of other countries and harming their interests. (Ministry of Foreign Affairs)
Individual stock news
1. Zhuoran Co., Ltd.: Significant order change from the original 6.936 billion yuan order down to 157 million yuan.
Zhuoran Co., Ltd. announced that its wholly-owned subsidiary Zhuoshuhua signed a fine chemical equipment-related order contract with Zhenhua Petroleum on April 14, 2023, with the original total order amount being 6.936 billion yuan. Affected by various factors such as market supply and demand conditions, on December 6, 2024, the company received a notice from Zhenhua Petroleum regarding project adjustments and subsequent changes. After friendly consultations with the owner, on December 10, 2024, it signed the 'Zhenhua Petroleum Chemical Co., Ltd. 260,000 tons/year maleic anhydride main device and its supporting modular design and manufacturing installation settlement agreement' and the 'Zhenhua Petroleum Chemical Co., Ltd. 400,000 tons/year butane reaction unit modular design and manufacturing installation EPC project and 30/67 tons/year PO/SM main device and its supporting modular design and manufacturing installation EPC project contract termination agreement.' The above agreements take effect from the date of signing, and the final settlement amount after the original order change is 157 million yuan.
2. Liangpinpuzi: Shareholder Dayong Limited has cumulatively reduced its holdings by 3% of the company's shares, and the reduction plan has been completed.
Liangpinpuzi announced that from October 31, 2024, to December 10, 2024, shareholder Dayong Limited reduced its holdings by a total of 12.03 million shares through centralized bidding and block trading, accounting for 3% of the company's total share capital, with a total reduction amount of approximately 142 million yuan. The reduction plan has been completed. After the reduction, Dayong Limited still holds more than 5% of the company's shares, holding 76.8361 million shares, accounting for 19.16% of the company's total share capital.
3. 15 days 9 boards Guang'an Aizhong: The company's stock price has been hitting the limit up for several days, and there is a considerable risk of decline in the future.
Guang'an Aizhong Announcement, on December 11, 2024, the company's stock turnover rate was 11.73%, with a trading volume of 919 million yuan. Since November 21, 2024, the company's stock has seen 9 trading days with the closing price hitting the limit up, with a cumulative turnover rate of 257.64%. Given that the company's stock price has been hitting the limit up for several days, but the company's fundamentals have not undergone significant changes, there is a considerable risk of decline in the future. Investors are advised to make rational decisions and invest prudently. After self-examination, the company has not found any media reports or market rumors that may have a significant impact on the company's stock trading price. As of the date of this announcement, the company is not involved in major asset restructuring, listed company acquisitions, or related planning, negotiations, intentions, agreements, etc.
4. 20CM two consecutive boards Lexin Technology: No plans to engage in specific complete machine business.
Lexin Technology announced that the stock trading price deviation of its closing price has accumulated more than 30% within three consecutive trading days, constituting a stock trading anomaly. Regarding the rumors about Lexin Technology being a supplier of ByteDance's Doubao AI toy and providing complete machine supply business, the company explained the relevant situation as follows: Lexin provides IoT chips, modules, and related software technical support for various industries but has no plans to engage in specific complete machine business. Each profession has its specialization, and there are usually industry solution providers to develop specific application solutions for particular industries.
5. Hubei Yihua: Plans to acquire 100% equity of Yichang Xinfatou for 3.208 billion yuan, constituting a major asset restructuring.
Hubei Yihua announced that the company intends to acquire 100% equity of Yichang Xinfatou held by its controlling shareholder Yihua Group for cash, with a transaction price of 3.208 billion yuan, constituting a related party transaction and a major asset restructuring. After the completion of this transaction, Yichang Xinfatou will become a wholly-owned subsidiary of the company, and the company's equity stake in Xinjiang Yihua will increase to 75%. Yichang Xinfatou is a holding platform company that, in addition to holding 39.403% equity in Xinjiang Yihua, does not hold equity in other companies and does not engage in specific businesses. Xinjiang Yihua mainly engages in the production and sales of PVC, caustic soda, urea, and other chemical fertilizers, with its major controlling subsidiary Yihua Mining primarily engaged in coal mining. After the completion of this transaction, the company's main business will include the production and sales of fertilizer products, chemical products, and coal, forming a complete upstream and downstream industrial chain in chemicals.
6. Modern Investment: The company's independent director Xu Qing is suspected of serious violations of discipline and law and is currently under disciplinary review and investigation by the Discipline Inspection Commission of the Industrial and Commercial Bank of China Hunan Branch and the Zhuzhou Municipal Supervisory Committee.
Modern Investment announced that the company's independent director Xu Qing is suspected of serious violations of discipline and law and is currently undergoing disciplinary review and investigation by the Discipline Inspection Commission of the Industrial and Commercial Bank of China Hunan Branch and the Zhuzhou Municipal Supervisory Committee. In addition to serving as an independent director, chairman of the Board Nomination Committee, member of the Board Strategic Committee, and member of the Board Audit Committee, Xu Qing does not hold any other positions in the company and does not participate in the daily management of the company. The company will pay attention to subsequent developments and strictly fulfill its information disclosure obligations in a timely manner in accordance with relevant regulations.
7. Fudan Fuhua: There are currently no clear clients for the sales agency activities of Benyuan Quantum, and there are no sales project filings.
Fudan Fuhua announced a stock trading anomaly notice. On August 5, 2024, the company was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure. On September 2, 2024, the company signed a strategic cooperation agreement with Benyuan Quantum to strengthen market layout and establish an industrial alliance, among other sales service-related strategic cooperation framework agreements, stipulating that our company serves as a sales service consultant, a non-exclusive agent, and Benyuan Quantum has the right to authorize other agents to conduct sales agency activities within our company's agency area. This sales agency activity requires project filing, and there are currently no clear clients or any sales project filings. This sales agency activity is not necessarily going to happen and is not a continuous business, having a certain degree of randomness.
8. 3 consecutive boards Huifa Food: Shareholder Zhenghechang reduced 1 million shares on December 11, and the reduction plan has not yet been completed.
Huifa Food announced that starting from December 9, 2024, the company's stock has been limit up for three consecutive trading days. On November 8, 2024, the company disclosed the Share Reduction Plan Announcement of Huifa Food, in which shareholder Zhenghechang Investment Co., Ltd. plans to reduce its holdings of no more than 2,446,400 shares through centralized bidding, accounting for no more than 1% of the company's total share capital; and to reduce no more than 4,892,800 shares through block trading, accounting for no more than 2% of the company's total share capital. The reduction plan period is from November 29, 2024, to February 27, 2025. On December 11, 2024, Zhenghechang Investment Co., Ltd. reduced its shareholding by 1 million shares through centralized bidding trading, and this shareholder's share reduction plan has not yet been completed.
9. 6 days 5 boards Ningbo Jingda: Both the company and Wuxi Weiyan do not engage in humanoid robot products and businesses.
Ningbo Jingda issued a stock trading risk warning announcement. The company's main business includes the research, development, production, and sales of stamping equipment, heat exchanger equipment, and micro-channel heat exchanger equipment. After self-examination, the company confirmed that its production and operation are normal, and there have been no significant changes in the internal and external business environment. Wuxi Weiyan's main business involves the research, development, production, and sales of precision molds, precision stamping parts, and micro-hole electrical discharge machine tools. Both the company and Wuxi Weiyan do not engage in humanoid robot products and businesses.
Article forwarded from: Jin Ten Data